Leeward Investments LLC MA Sells 57,514 Shares of Envista Holdings Co. (NYSE:NVST)
by Michael Walen · The Markets DailyLeeward Investments LLC MA reduced its position in shares of Envista Holdings Co. (NYSE:NVST – Free Report) by 9.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 583,075 shares of the company’s stock after selling 57,514 shares during the quarter. Leeward Investments LLC MA owned about 0.34% of Envista worth $11,522,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of NVST. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Envista in the 3rd quarter worth approximately $31,000. GAMMA Investing LLC lifted its holdings in Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after buying an additional 726 shares during the period. Blue Trust Inc. lifted its holdings in Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after buying an additional 804 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares during the period. Finally, Versant Capital Management Inc increased its holdings in shares of Envista by 1,420.3% in the 2nd quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock valued at $52,000 after acquiring an additional 2,940 shares during the period.
Insiders Place Their Bets
In related news, CFO Eric D. Hammes purchased 24,532 shares of the company’s stock in a transaction dated Monday, August 12th. The stock was acquired at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the completion of the transaction, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by corporate insiders.
Envista Stock Performance
Shares of NVST stock opened at $21.89 on Thursday. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $25.64. The business’s 50 day moving average is $18.75 and its two-hundred day moving average is $18.07. The company has a market capitalization of $3.77 billion, a P/E ratio of -2.82, a P/E/G ratio of 3.03 and a beta of 1.30.
Envista (NYSE:NVST – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.03. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The business had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. During the same quarter last year, the business earned $0.43 earnings per share. The company’s revenue for the quarter was down 4.8% compared to the same quarter last year. Analysts expect that Envista Holdings Co. will post 0.7 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently issued reports on NVST shares. Evercore ISI lifted their price objective on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Bank of America decreased their price objective on Envista from $22.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and raised their price target for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Finally, Robert W. Baird upped their price objective on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $20.71.
Check Out Our Latest Analysis on Envista
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
- Five stocks we like better than Envista
- Consumer Staples Stocks, Explained
- Top 3 Sectors Outperforming After Trump’s Victory
- Using the MarketBeat Stock Split Calculator
- Sono-Tek’s $2M Buyback: A Buying Opportunity in Clean Tech
- 3 REITs to Buy and Hold for the Long Term
- MGM vs. Las Vegas Sands: Which Casino Stock Is the Better Bet?